Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT - Quiz - MDSpire

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT

  • By

  • Nico Gagelmann

  • Maximilian Merz

  • Laurien G. A. Baaij

  • Linda Koster

  • Jorinde D. Hoogenboom

  • Joanna Drozd-Sokolowska

  • Kavita Raj

  • Jürgen Kuball

  • Patrick J. Hayden

  • Florent Malard

  • Laurent Garderet

  • Annalisa Ruggeri

  • Donal McLornan

  • March 31, 2026

  • 0 min

Share

Original Source(s)

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT

  • by Nico Gagelmann, Maximilian Merz, Laurien G. A. Baaij, Linda Koster, Jorinde D. Hoogenboom, Joanna Drozd-Sokolowska, Kavita Raj, Jürgen Kuball, Patrick J. Hayden, Florent Malard, Laurent Garderet, Annalisa Ruggeri, Donal McLornan

  • March 31, 2026

Related Content

Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma

Efficacy of Quadruplet Therapy with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone as Initial Treatment for High-Risk Multiple Myeloma Patients in China: Findings from a Multi-Center Real-World Study

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study